Alteration of centrally mediated cardiovascular manifestations by intraventricular pronethalol and phentolamine.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D002552:Cerebral Ventricles; D002746:Chlorpromazine / Q000494:pharmacology; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D007099:Imipramine / Q000494:pharmacology; D007267:Injections; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000008:administration & dosage*; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology
D004983:Ethanolamines; D012110:Reserpine; D007099:Imipramine; D002746:Chlorpromazine; D009638:Norepinephrine; D010646:Phentolamine